Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial
European Journal of Cancer · 2023-12 · 195 · 113286
DOI: 10.1016/j.ejca.2023.113286 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2023-12. Verfasst von Wen-Kuan Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou branch, College of Medicine, Chang Gung Univer…. Hauptthemen laut MEDLINE: Zinc, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Chang Gung Medical Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou branch, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou branch, Taipei, Keelung, Taoyuan, Taiwan; Chang Gung Immunology Consortium, Chang Gung Memorial Hospita…
- Department of General Surgery, GIST team, and Liver Research Center, Chang Gung Memorial Hospital, Linkou branch, Chang Gung University, Taoyuan, Taiwan.
- Cancer Vaccine and Immune Cell Therapy Core Laboratory, Department of Medical Research, Chang Gung Memorial Hospital, Linkou branch, Taoyuan, Taiwan; Institute of Pharmacology, School of Medicine, National Yang Ming Chi…
- Department of General Surgery, GIST team, and Liver Research Center, Chang Gung Memorial Hospital, Linkou branch, Chang Gung University, Taoyuan, Taiwan. Electronic address: yehchunnan@gmail.com.
Förderung
- Chang Gung Medical Foundation
Zitieren
APA
Huang, W. K., Hsu, H. C., Yang, T. S., Lu, C. W., Pan, Y. R., Wu, C. E., Chung, W. H., Hung, S. I., & Yeh, C. N. (2023). Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial. European Journal of Cancer, 195, 113286. https://doi.org/10.1016/j.ejca.2023.113286
Vancouver
Huang WK, Hsu HC, Yang TS, Lu CW, Pan YR, Wu CE, et al. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial. European Journal of Cancer. 2023;195:113286. doi:10.1016/j.ejca.2023.113286
BibTeX
@article{Huang2023,
author = {Huang, Wen-Kuan and Hsu, Hung-Chih and Yang, Tsai-Sheng and Lu, Chun-Wei and Pan, Yi-Ru and Wu, Chiao-En and Chung, Wen-Hung and Hung, Shuen-Iu and Yeh, Chun-Nan},
title = {Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial},
journal = {European Journal of Cancer},
year = {2023},
volume = {195},
pages = {113286},
doi = {10.1016/j.ejca.2023.113286}
}
EUVIMED